ZLAB:NASDAQ, Zai Lab Limited
ZLAB stock overview
Zai Lab Limited (ZLAB:NASDAQ) closed at $21.03 on November 20, 2026,
down 4.06% on the day.
The stock trades 27.5% below its 52-week high of $29.02
and 31.8% above its 52-week low of $15.96.
Over the past year, it gained 5.0%.
Zai Lab Limited is part of the Health Care sector (Major Pharmaceuticals).
Key figures
- Price
- $21.03
- Day change
- -4.06%
- Volume
- 1,442,215
- Average volume
- 984,451
- Market cap
- 2B+
- 52-week range
- $15.96 – $29.02
- 50-day average
- $24.42
- 200-day average
- $21.42
Price action over the past year
In 252 trading sessions since November 20, 2025, ZLAB closed higher on 111 days (44%).
Its best day was August 6, 2026 (+13.66%) and its worst was October 22, 2026 (-8.93%).
The stock moved 10% or more in a single session 4 times.
It opened at least 5% above the previous day's high 1 time.
Recent signals
ZLAB news
-
Nov 21, 2026:
3 Biotech Stocks With Revenue Growth Up To 26%
-
Nov 16, 2026:
China's ZAI, Minimax tumble as Nvidia row drives fears of more chip restrictions
-
Nov 14, 2026:
Top 3 Healthcare Stocks To Watch In November 2026
-
Nov 14, 2026:
Zai Lab Announces First-Time Inclusion of KarXT and VYVGART Hytrulo in Chinas 2026 National Reimbursement Drug List, Expanding Access to Key Growth Products
-
Nov 14, 2026:
Zai Lab Announces First-Time Inclusion of KarXT and VYVGART Hytrulo® in China's 2026 National Reimbursement Drug List, Expanding Access to Key Growth Products
-
Nov 13, 2026:
Zai Lab Announces Participation in Investor Conferences in November 2026
-
Nov 13, 2026:
Zai Lab Advances Atopic Dermatitis Candidate Toward Potential Quarterly Maintenance Dosing
-
Nov 13, 2026:
Zai Lab Presents Positive First-in-Human Data for ZL-1503, a Novel IL-13/IL-31R Bispecific, Demonstrating Rapid and Sustained Inhibition of Key Atopic Dermatitis Biomarkers and Extended Serum Half-Life Supporting Less Frequent Dosing
About Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company. The company is engaged in discovering or licensing, developing and commercializing proprietary therapeutics in the fields of oncology, autoimmune and infectious diseases.
Similar stocks
Find more stocks like ZLAB with the
Spikes,
Gaps,
Breakouts and
Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.